SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Integrated Proteins Ltd (519606)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519606 NSE: Trading | Small Cap | Integ.Pro Share Price

₹138 1.75 (1.28%)

As on 04-Jun'26 16:59

Integrated Proteins Ltd (519606)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519606 NSE: Trading | Small Cap | Integ.Pro Share Price

₹138 1.75 (1.28%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹258 Cr.
Current Price
₹138
52-Week Low / High
₹21 / 140
TTM EPS
₹0.1
TTM Sales
₹9.9 Cr.
Book Value per Share
₹10.8
P/E Ratio
1142.69
Higher than its 5-year historical median
Industry PE
36
Price to Book (P/B)
12.78
Higher than its 5-year historical median
Price to Sales (P/S)
25.99
Higher than its 5-year historical median
EV/EBITDA
909.38
Higher than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
10.34%
Outperforms industry median
Return on Capital Employed (ROCE)
2.40%
Underperforms industry median
Return on Assets (ROA)
1.42%
Operating Profit Margin
0.5%
Net Profit Margin
1.16%
Gross Profit Margin
1.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
8858.33%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
177.78%
Asset Quality
Promoter Holding
2.23%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1 Cr.
Equity
₹18.7 Cr.
Face Value
₹10
All Time Low / High
₹1.55 / 139.65

Integrated Proteins stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Not Good
Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Weak
Check Price chart
Q.1 Is Integrated Proteins Ltd a good quality company?
Integrated Proteins Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Integrated Proteins Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Integrated Proteins Ltd vs industry peers?
Integrated Proteins Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 4.99%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Integrated Proteins Ltd?
Promoters hold 2.23% of the Integrated Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Integrated Proteins Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 51.3% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Integrated Proteins Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ3.4%3.3%2.5%0.2%0.8%1.2%2%1.6%3.9%2.4%-
Value Creation
Index ⓘ		-0.8-0.8-0.8-1.0-1.0-0.9-0.9-0.9-0.7-0.8-

Growth Parameters ⓘ
Sales ⓘ0.10000000.20.221.510
Sales YoY Gr.--100%NANANANANANA41.2%8,858.3%-
Adj EPS ⓘ0.20.100.100.10.10.10.10.60.1
YoY Gr.--43.5%-69.2%100%-75%250%57.1%-9.1%-20%675%-
BVPS (₹) ⓘ7.17.26.96.66.66.76.86.97.27.910.8
Adj Net
Profit ⓘ		0.10.100000000.20
Cash Flow from Ops. ⓘ-0.1-0.2-0.2-0.1-0.2-0.1-0.1-0.1-0.1-23.6-
Debt/CF from Ops. ⓘ00000-0.4-0.9-1.6-0.6-0.2-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ86.2%NANA8858.3%
Adj EPS ⓘ11.7%98.7%78%675%
BVPSⓘ1.3%3.7%5.4%10.8%
Share Price 51.7% 111.8% 139.6% 211.5%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		3.41.90.510.20.91.51.211.71.3
Op. Profit
Mgn % ⓘ		-77.6000000-51.1-49.90.53.2
Net Profit
Mgn % ⓘ		102.400000018.510.30.92.3
Debt to
Equity ⓘ		00000000.101.40
Working Cap
Days ⓘ		6,9350000004,7953,371292234
Cash Conv.
Cycle ⓘ		-1,298000000-100-39-69190

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00000000021
Operating Expenses ⓘ + 00000000021
Manufacturing Costs0000000000
Material Costs00000000021
Employee Cost 0000000000
Other Costs ⓘ 0000000000
Operating Profit ⓘ -0-0-0-0-0-0-0-0-00
Operating Profit Margin (%) -77.6%-------51.1%-49.9%0.4%
Other Income ⓘ + 0000000000
Exceptional Items ⓘ 0000000000
Interest ⓘ 0000000000
Depreciation ⓘ 0000000000
Profit Before Tax ⓘ 0000000000
Tax ⓘ 000-0000000
Profit After Tax 0000000000
PAT Margin (%) 102.4%------18.5%37.6%1.2%
Adjusted EPS (₹)0.20.10.00.10.00.10.10.10.30.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Integ.Pro - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 2332222333
Share Capital ⓘ 4444444444
Reserves ⓘ -1-1-1-1-1-1-1-1-1-1
Debt +0000000004
Long Term Debt0000000000
Short Term Debt0000000004
Minority Interest0000000000
Trade Payables0000000008
Others Liabilities ⓘ 00000000018
Total Liabilities ⓘ 33333333332

Fixed Assets

Net Fixed Assets ⓘ +1111000000
Gross Block1111111111
Accumulated Depreciation0011111111
CWIP ⓘ 0000000000
Investments ⓘ 0000000000
Inventories0000000000
Trade Receivables0000000000
Cash Equivalents 0000000000
Others Assets ⓘ 22222222232
Total Assets ⓘ 33333333332

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + -0-0-0-0-0-0-0-0-0-24
PBT ⓘ 0000000000
Adjustment ⓘ -0-0-0-0-0-0-0-0-0-0
Changes in Working Capital ⓘ -0-0-00-00-0-0-0-24
Tax Paid ⓘ 00-0-0-00-0-0-0-0
Cash Flow From Investing Activity ⓘ + 0000000-002
Capex 0000000000
Net Investments 0000000-000
Others ⓘ 0000000002
Cash Flow From Financing Activity ⓘ + 000-00000-021
Net Proceeds from Shares ⓘ 00000000017
Net Proceeds from Borrowing ⓘ 00000000-0-0
Interest Paid ⓘ 000-0000000
Dividend Paid ⓘ 0000000000
Others ⓘ 0000000004
Net Cash Flow ⓘ 0-0-0-0-0-0-0-0-00

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.391.910.511.140.2611.691.413.9710.34
ROCE (%)3.433.342.540.150.761.171.951.593.892.4
Asset Turnover Ratio0.030000000.060.091.22
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days86.80000000000
Inventory Days0000000000
Payable Days0000000135.1057.1069.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Integrated Proteins Ltd FAQs

The current trading price of Integ.Pro on 04-Jun-2026 16:59 is ₹138.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Integ.Pro stood at ₹258.2 Cr

The latest P/E ratio of Integ.Pro as of 03-Jun-2026 is 1,142.7.

The latest P/B ratio of Integ.Pro as of 03-Jun-2026 is 12.78.

The 52-week high of Integ.Pro is ₹139.7 and the 52-week low is ₹20.71.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Integ.Pro is ₹9.94 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Integrated Proteins Ltd is a below average quality company.

The key valuation ratios of Integrated Proteins Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Integrated Proteins Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Integrated Proteins Ltd

Integrated Proteins Limited was incorporated on October 14, 1992. Since inception, the Company is engaged in processing of various oil seeds like soyabean, mustard/ rapeseed, groundnut, etc. business with wide /various range depending on ultimate application of the products. However, Gujarat enjoys a strong position with regard to availability of groundnut and mustard/rapeseed.

Business area of the company

The company is engaged in the business of Trading in processing of various oil seeds like soyabean, musted/rapeseed, groundnut, etc. business with wide/various range depending on ultimate application of the products. The main object of the company is to cater to the growing industry and offer its products to all the age groups. The company is slowly processing towards becoming a one stop shop for all the retailers.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×